Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method-Reference-Cited by-同舟云学术

Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method

Published:2020-05-08 Issue:1 Volume:62 Page:37-42
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Rekowski Jan,Hüttmann Andreas,Schmitz Christine,Müller Stefan P.,Kurch Lars,Kotzerke Jörg,Franzius Christiane,Weckesser Matthias,Bengel Frank M.,Freesmeyer Martin,Hertel Andreas,Krohn Thomas,Holzinger Jens,Brink Ingo,Haberkorn Uwe,Nyuyki Fonyuy,van Assema Daniëlle M.E.,Geworski Lilli,Hasenclever Dirk,Jöckel Karl-Heinz,Dührsen Ulrich

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference24 articles.

1. Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

2. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial;Poeschel;Lancet.,2020

3. Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: post-hoc analysis from the PETAL trial;Schmitz;Eur J Cancer.,2020

4. Positron emission tomography–guided therapy of aggressive non-Hodgkin lymphomas (PETAL): a multicenter, randomized phase III trial;Dührsen;J Clin Oncol.,2018

5. Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis;Burggraaff;Eur J Nucl Med Mol Imaging.,2019

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Axial Field-of-View PET Imaging in Patients with Lymphoma;PET Clinics;2024-10

2. 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas;PET Clinics;2024-10

3. Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial;Blood Neoplasia;2024-09

4. Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy;Cancer Imaging;2024-07-09

5. A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL;Frontiers in Oncology;2024-03-21